Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001618
Filing Date
2024-02-14
Accepted
2024-02-14 09:25:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 KRYSTAL BIOTECH, INC. p24-0154sc13ga.htm SC 13G/A 57936
  Complete submission text file 0000902664-24-001618.txt   59629
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Subject) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90133 | Film No.: 24633072
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)